Therapy of autoimmune bullous diseases

19Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling inflammation and improving healing of erosions. The therapeutic agents used in the treatment of bullous diseases may be associated with high morbidity and occasional mortality. Successful treatment requires understanding of the pathophysiology of the disease process and the pharmacology of the drugs being used. © 2007 Dove Medical Press Limited. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Mutasim, D. F. (2007). Therapy of autoimmune bullous diseases. Therapeutics and Clinical Risk Management. https://doi.org/10.2147/tcrm.2007.3.1.29

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free